Shop
Genovior focuses on sterile injectable drugs and is one of the leading CDMO companies that spans across various technological fields:
Genovior provides comprehensive services from R&D to PIC/S GMP production for API and FDF drugs, with advanced facilities in National Science Park in Taiwan. Genovior has products in four main categories:
Genovior looks for licensing and CDMO opportunity and will be your reliable partner!

Year of Establishment: 2015
Total Number of Staff: 100-500
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Quality Service
Other Competitive Advantages:
Patents and Copyrights: